Eli Lilly to invest $450 million more to expand capacity as obesity drug decision looms Reuters Jan 25, 2023 The company has been struggling to meet strong demand for its incretin products, which include its diabetes drug Trulicity and…
Eli Lilly and Cipla enter into strategic partnership in India to enhance access to Lilly’s key… EP News Bureau Oct 4, 2021 As part of this agreement, Lilly will transfer its rights in India to sell, promote and distribute the aforesaid two Lilly…
Global diabetes therapeutic market has grown sixfold in last two decades: GlobalData EP News Bureau May 19, 2021 The market has been a lucrative space for drug developers, as the disease is highly prevalent and patient numbers are expected to…
Lilly gets US FDA nod for additional doses of Trulicity (dulaglutide) to treat type 2 diabetes EP News Bureau Sep 5, 2020 The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11 trial